In ER+ grade I breast adenocarcinomas, TRPM8 expression is normally upregulated (293, 341), with comparatively higher expression of TRPM8 mRNA in the highly invasive MDA-MB-231 cell line. Here, TRPM8 is linked to breast adenocarcinoma.